GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (OTCPK:VPTDF) » Definitions » Stock Based Compensation

VPTDF (VentriPoint Diagnostics) Stock Based Compensation : $0.51 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is VentriPoint Diagnostics Stock Based Compensation?

VentriPoint Diagnostics's Stock Based Compensation for the three months ended in Dec. 2024 was $0.02 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was $0.51 Mil.


VentriPoint Diagnostics Stock Based Compensation Historical Data

The historical data trend for VentriPoint Diagnostics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Stock Based Compensation Chart

VentriPoint Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.70 0.59 0.37 0.48

VentriPoint Diagnostics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.04 0.06 0.38 0.02

VentriPoint Diagnostics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51 Mil.


VentriPoint Diagnostics Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics Headlines

From GuruFocus